Skip to main content

Table 1 Baseline Characteristics of Prevaccinated Asthma Patients on Both Groups

From: Clinical Efficacy and Laboratory Improvement of Bacillus Calmette-Guerin Vaccination on Adult Atopic Asthma A Cohort Study

Characteristics BCG Group (n = 20) Placebo Group (n = 20) P
Sex (male/female) 10 (50%)/10 (50%) 8 (40%)/12 (60%) 0.990
Age, yrs (mean ± SD) 34.95 ± 11.55 34.90 ± 12.32 0.675
Body mass index, kg/m2 (mean ± SD) 23.35 ± 3.16 22.97 ± 2.70 0.689
Old healed TBC lesions 0 0 0.5
History of anti-TBC drugs 0 0 0.5
Previous BCG vaccination scar 14 (70%) 15 (75%) 0.517
Asthma triggers, no. (%)    
   Dust mite 12 (60) 13 (65) > 0.05
   Cold air 10 (50) 8(40) > 0.05
   Pollutant 9 (45) 8 (40) > 0.05
   Drugs 4 (20) 4 (20) > 0.05
   Seafood 2 (10) 4 (20) > 0.05
   Pollen 1 (5) 0 > 0.05
Duration of asthma, yrs (no. [%])    
   1-3 2 (10) 3 (15) > 0.05
   3-5 4 (20) 5 (25) > 0.05
   5-10 9 (45) 8 (40) > 0.05
   > 10 5 (25) 4 (20) > 0.05
Asthma grading (GINA 2002)    
   Mild persistent 6 (30%) 6 (30%) 0.5
   Moderate persistent 14 (70%) 14 (70%) 0.5
Hemoglobin, g/dL 14.76 ± 1.53 14.42 ± 1.68 0.508
Eosinophil in differentialcount, % 9.85 ± 6.70 9.80 ± 6.52 0.190
Student t test for continuous variables; Fisher exact test for categorical variables.